Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics

Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1 %), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia & lymphoma 1996, Vol.21 (1-2), p.131-136
Hauptverfasser: Economopoulos, Theofanis, Asprou, Niki, Stathakis, Nicholas, Papageorgiou, Efstathios, Dervenoulas, John, Xanthaki, Katiana, Raptis, Sotos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 136
container_issue 1-2
container_start_page 131
container_title Leukemia & lymphoma
container_volume 21
creator Economopoulos, Theofanis
Asprou, Niki
Stathakis, Nicholas
Papageorgiou, Efstathios
Dervenoulas, John
Xanthaki, Katiana
Raptis, Sotos
description Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1 %), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade) predominated. 89.6% of the cases were localized (stage Ie, 51% and stage II, 38.6%) but 28% had B symptoms. CR was achieved in 82.1 % of the cases. 5-years disease free survival and overall survival were both 65%. Factors that influence prognosis were stage and high grade histology. Among various primary sites the Waldeyer's ring, small intestine and testes had the worse prognosis. Compared to nodal NHL, the PE-NHL were more frequently localized, belonged more often to aggressive histologies and had more often distal extranodal relapses. CR rates and disease free and overall survival were significantly better for PE-NHL. The survival rates, however, listed according to stage and histology for nodal and PE-NHL were not different. We conclude that although PE-NHL differed from nodal NHL in several respects, prognosis is mainly a factor of stage and histology rather than of the primary localization per se.
doi_str_mv 10.3109/10428199609067590
format Article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_3109_10428199609067590</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78524361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-9c587659523e8b09ca63f775824b9e685ff8cdc2e903225d2459aae71bbfd7a53</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVoSfP1A3Io-NSc3EqyZUltLmFJmsCSFtKezViSY6WytJHktPvv42WXQCjtaWZ4PxgehE4J_lgRLD8RXFNBpGywxA1nEu-hA4KpLGmNqzebvablbKjfocOUHjDGTDZ0H-0LiTkV-ACZ79GOENfF5Z8cwQcNrrgNvrwO-v6X9WepWK7H1RBGKKwvLvTkcvpcLJz1VoUV5CG4cG_VnAKvi7spPtmn-VgMEEFlE23KVqVj9LYHl8zJbh6hn1eXPxbX5fLb15vFxbJUdcNzKRUTvGGS0cqIDksFTdVzzgStO2kawfpeKK2okbiilGlaMwlgOOm6XnNg1RH6sO1dxfA4mZTb0SZlnANvwpRaLhitq4bMRrI1qhhSiqZvV1sOLcHtBm37F9o5835XPnWj0S-JHctZP9_q1vchjvA7RKfbDGsXYj-zVTZtqv9d_-VVfDDg8qAgmvYhTNHP3P7z3DP2J5pG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78524361</pqid></control><display><type>article</type><title>Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics</title><source>MEDLINE</source><source>Taylor &amp; Francis Medical Library - CRKN</source><source>Taylor &amp; Francis Journals Complete</source><creator>Economopoulos, Theofanis ; Asprou, Niki ; Stathakis, Nicholas ; Papageorgiou, Efstathios ; Dervenoulas, John ; Xanthaki, Katiana ; Raptis, Sotos</creator><creatorcontrib>Economopoulos, Theofanis ; Asprou, Niki ; Stathakis, Nicholas ; Papageorgiou, Efstathios ; Dervenoulas, John ; Xanthaki, Katiana ; Raptis, Sotos</creatorcontrib><description>Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1 %), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade) predominated. 89.6% of the cases were localized (stage Ie, 51% and stage II, 38.6%) but 28% had B symptoms. CR was achieved in 82.1 % of the cases. 5-years disease free survival and overall survival were both 65%. Factors that influence prognosis were stage and high grade histology. Among various primary sites the Waldeyer's ring, small intestine and testes had the worse prognosis. Compared to nodal NHL, the PE-NHL were more frequently localized, belonged more often to aggressive histologies and had more often distal extranodal relapses. CR rates and disease free and overall survival were significantly better for PE-NHL. The survival rates, however, listed according to stage and histology for nodal and PE-NHL were not different. We conclude that although PE-NHL differed from nodal NHL in several respects, prognosis is mainly a factor of stage and histology rather than of the primary localization per se.</description><identifier>ISSN: 1042-8194</identifier><identifier>EISSN: 1029-2403</identifier><identifier>DOI: 10.3109/10428199609067590</identifier><identifier>PMID: 8907280</identifier><language>eng</language><publisher>United States: Informa UK Ltd</publisher><subject>Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; extranodal ; Female ; Follow-Up Studies ; Humans ; Lymph Nodes - pathology ; Lymphoma ; Lymphoma, Non-Hodgkin - mortality ; Lymphoma, Non-Hodgkin - pathology ; Lymphoma, Non-Hodgkin - therapy ; Male ; Middle Aged ; Neoplasm Staging ; non-Hodgkin's ; Prognosis ; Sex Factors</subject><ispartof>Leukemia &amp; lymphoma, 1996, Vol.21 (1-2), p.131-136</ispartof><rights>1996 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1996</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-9c587659523e8b09ca63f775824b9e685ff8cdc2e903225d2459aae71bbfd7a53</citedby><cites>FETCH-LOGICAL-c467t-9c587659523e8b09ca63f775824b9e685ff8cdc2e903225d2459aae71bbfd7a53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/10428199609067590$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/10428199609067590$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,4024,27923,27924,27925,59647,59753,60436,60542,61221,61256,61402,61437</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8907280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Economopoulos, Theofanis</creatorcontrib><creatorcontrib>Asprou, Niki</creatorcontrib><creatorcontrib>Stathakis, Nicholas</creatorcontrib><creatorcontrib>Papageorgiou, Efstathios</creatorcontrib><creatorcontrib>Dervenoulas, John</creatorcontrib><creatorcontrib>Xanthaki, Katiana</creatorcontrib><creatorcontrib>Raptis, Sotos</creatorcontrib><title>Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics</title><title>Leukemia &amp; lymphoma</title><addtitle>Leuk Lymphoma</addtitle><description>Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1 %), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade) predominated. 89.6% of the cases were localized (stage Ie, 51% and stage II, 38.6%) but 28% had B symptoms. CR was achieved in 82.1 % of the cases. 5-years disease free survival and overall survival were both 65%. Factors that influence prognosis were stage and high grade histology. Among various primary sites the Waldeyer's ring, small intestine and testes had the worse prognosis. Compared to nodal NHL, the PE-NHL were more frequently localized, belonged more often to aggressive histologies and had more often distal extranodal relapses. CR rates and disease free and overall survival were significantly better for PE-NHL. The survival rates, however, listed according to stage and histology for nodal and PE-NHL were not different. We conclude that although PE-NHL differed from nodal NHL in several respects, prognosis is mainly a factor of stage and histology rather than of the primary localization per se.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Combined Modality Therapy</subject><subject>extranodal</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphoma</subject><subject>Lymphoma, Non-Hodgkin - mortality</subject><subject>Lymphoma, Non-Hodgkin - pathology</subject><subject>Lymphoma, Non-Hodgkin - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>non-Hodgkin's</subject><subject>Prognosis</subject><subject>Sex Factors</subject><issn>1042-8194</issn><issn>1029-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVoSfP1A3Io-NSc3EqyZUltLmFJmsCSFtKezViSY6WytJHktPvv42WXQCjtaWZ4PxgehE4J_lgRLD8RXFNBpGywxA1nEu-hA4KpLGmNqzebvablbKjfocOUHjDGTDZ0H-0LiTkV-ACZ79GOENfF5Z8cwQcNrrgNvrwO-v6X9WepWK7H1RBGKKwvLvTkcvpcLJz1VoUV5CG4cG_VnAKvi7spPtmn-VgMEEFlE23KVqVj9LYHl8zJbh6hn1eXPxbX5fLb15vFxbJUdcNzKRUTvGGS0cqIDksFTdVzzgStO2kawfpeKK2okbiilGlaMwlgOOm6XnNg1RH6sO1dxfA4mZTb0SZlnANvwpRaLhitq4bMRrI1qhhSiqZvV1sOLcHtBm37F9o5835XPnWj0S-JHctZP9_q1vchjvA7RKfbDGsXYj-zVTZtqv9d_-VVfDDg8qAgmvYhTNHP3P7z3DP2J5pG</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>Economopoulos, Theofanis</creator><creator>Asprou, Niki</creator><creator>Stathakis, Nicholas</creator><creator>Papageorgiou, Efstathios</creator><creator>Dervenoulas, John</creator><creator>Xanthaki, Katiana</creator><creator>Raptis, Sotos</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1996</creationdate><title>Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics</title><author>Economopoulos, Theofanis ; Asprou, Niki ; Stathakis, Nicholas ; Papageorgiou, Efstathios ; Dervenoulas, John ; Xanthaki, Katiana ; Raptis, Sotos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-9c587659523e8b09ca63f775824b9e685ff8cdc2e903225d2459aae71bbfd7a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Combined Modality Therapy</topic><topic>extranodal</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphoma</topic><topic>Lymphoma, Non-Hodgkin - mortality</topic><topic>Lymphoma, Non-Hodgkin - pathology</topic><topic>Lymphoma, Non-Hodgkin - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>non-Hodgkin's</topic><topic>Prognosis</topic><topic>Sex Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Economopoulos, Theofanis</creatorcontrib><creatorcontrib>Asprou, Niki</creatorcontrib><creatorcontrib>Stathakis, Nicholas</creatorcontrib><creatorcontrib>Papageorgiou, Efstathios</creatorcontrib><creatorcontrib>Dervenoulas, John</creatorcontrib><creatorcontrib>Xanthaki, Katiana</creatorcontrib><creatorcontrib>Raptis, Sotos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Leukemia &amp; lymphoma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Economopoulos, Theofanis</au><au>Asprou, Niki</au><au>Stathakis, Nicholas</au><au>Papageorgiou, Efstathios</au><au>Dervenoulas, John</au><au>Xanthaki, Katiana</au><au>Raptis, Sotos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics</atitle><jtitle>Leukemia &amp; lymphoma</jtitle><addtitle>Leuk Lymphoma</addtitle><date>1996</date><risdate>1996</risdate><volume>21</volume><issue>1-2</issue><spage>131</spage><epage>136</epage><pages>131-136</pages><issn>1042-8194</issn><eissn>1029-2403</eissn><abstract>Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1 %), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade) predominated. 89.6% of the cases were localized (stage Ie, 51% and stage II, 38.6%) but 28% had B symptoms. CR was achieved in 82.1 % of the cases. 5-years disease free survival and overall survival were both 65%. Factors that influence prognosis were stage and high grade histology. Among various primary sites the Waldeyer's ring, small intestine and testes had the worse prognosis. Compared to nodal NHL, the PE-NHL were more frequently localized, belonged more often to aggressive histologies and had more often distal extranodal relapses. CR rates and disease free and overall survival were significantly better for PE-NHL. The survival rates, however, listed according to stage and histology for nodal and PE-NHL were not different. We conclude that although PE-NHL differed from nodal NHL in several respects, prognosis is mainly a factor of stage and histology rather than of the primary localization per se.</abstract><cop>United States</cop><pub>Informa UK Ltd</pub><pmid>8907280</pmid><doi>10.3109/10428199609067590</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1042-8194
ispartof Leukemia & lymphoma, 1996, Vol.21 (1-2), p.131-136
issn 1042-8194
1029-2403
language eng
recordid cdi_informahealthcare_journals_10_3109_10428199609067590
source MEDLINE; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete
subjects Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Combined Modality Therapy
extranodal
Female
Follow-Up Studies
Humans
Lymph Nodes - pathology
Lymphoma
Lymphoma, Non-Hodgkin - mortality
Lymphoma, Non-Hodgkin - pathology
Lymphoma, Non-Hodgkin - therapy
Male
Middle Aged
Neoplasm Staging
non-Hodgkin's
Prognosis
Sex Factors
title Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T06%3A08%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20Extranodal%20Non-Hodgkin's%20Lymphoma%20in%20Adults:%20Clinicopathological%20and%20Survival%20Characteristics&rft.jtitle=Leukemia%20&%20lymphoma&rft.au=Economopoulos,%20Theofanis&rft.date=1996&rft.volume=21&rft.issue=1-2&rft.spage=131&rft.epage=136&rft.pages=131-136&rft.issn=1042-8194&rft.eissn=1029-2403&rft_id=info:doi/10.3109/10428199609067590&rft_dat=%3Cproquest_infor%3E78524361%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78524361&rft_id=info:pmid/8907280&rfr_iscdi=true